Кудинова Елена Александровна
Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology · 64 works · 67 citations · h-index 5
Top works
- Studying of the effect of the genetic variant c.470T>C in the CHEK2 gene on increasing the risk of breast cancer in the population of the Russian Federation
- New targeted anti CDK4/6 peptide MM-D37K.
- Monitoring of breast cancer progression via aptamer-based detection of circulating tumor cells in clinical blood samples
- Characteristics of BRCA-associated breast cancer in the population of the Russian Federation
- Radiogenomics of breast cancer as new vector of interdisciplinary integration of radiation and molecular biological technologies (literature review)
- Safety assessment and determination of a maximally tolerated dose of an RAS-GTPase inhibitor (iRAS) in the treatment of gastrointestinal tumors: preliminary results of the phase I trial
- Investigation of the expression level of genes-markers of proliferative activity in the mucosa at normal and various pathologies of the colon
- Correlation of the molecular biological subtype of primary tumor and regional metastases in breast cancer patients
- Mammaglobin in peripheral blood and tumor in breast cancer patients
- Study of the suppression of a tumor growth expressing a carcinoembryonic antigen with a new high-tech drug carplasmin (CAR-T therapy) in Balb/c nude mice
- MOLECULAR BIOLOGICAL AND RADIOLOGICAL TECHNOLOGIES IN THE COMPLEX DIAGNOSIS OF AUXILIARY PATHOLOGY
- Prognostic possibilities of gene expression profiling to identify a risk for recurrent breast cancer after organ-sparing treatment
- Mammaglobin in peripheral blood and the tumor of breast cancer patients
- Cytokeratin 19 mRNA concentration in lymph nodes as a diagnostic marker of metastases
- Changes in the concentration of freely circulating mutant DNA and wild-type DNA of the H3F3А (K27M) gene in the blood and cerebrospinal fluid of children with diffuse midline gliomas during a course of radiation therapy
- Results of a Phase IIa clinical trial of a RAS-GTPase inhibitor (Ing-Ras) for the treatment of gastrointestinal tumors
- Mammaglobin mRNA expression as early breast cancer marker
- Optimization of CAR-T technology to improve the effectiveness of therapy for solid tumors
- Specific antitumor activity of anti-CA125 CAR-T lymphocytes against CA125-positive and CA125-negative cells
- Optimization of IVT-mRNA nucleofection efficiency for non- activated peripheral blood lymphocytes